Gyre Therapeutics, Inc 10-Q for FY2025 Q3
Gyre Therapeutics, Inc. (GYRE)
10-Q
2025-11-07
For: 2025-09-30
View Original
Added on
April 08, 2026
About this 10-Q
Gyre Therapeutics, Inc filed this 10-Q on November 7, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).
Headline figures
Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $30.56M
- up 19.9% from $25.49M a year earlier
- Net income
- $5.94M
- up 107.8% from net income of $2.86M a year earlier
- Diluted EPS
- $0.03
- up 200.0% from $0.01 a year earlier